53
Growth Score
pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
446269
ViroPharma, a biopharmaceutical company, engages in the development and commercialization of products that address serious diseases
About the Company
ViroPharma Incorporated, a biopharmaceutical company, engages in the development and commercialization of products that address serious diseases, with a focus on products used by physician specialists or in hospital settings. The company has two marketed products, and three development programs. The company markets and sells Vancocin HCl capsules,
the oral capsule formulation of vancomycin hydrochloride, in the U.S. and its territories. Vancocin is a potent antibiotic approved by the U.S. Food and Drug Administration, or the FDA, to treat antibiotic-associated pseudomembranous colitis caused by Clostridium difficile infection (CDI), or C. difficile, and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains.
